181 related articles for article (PubMed ID: 37846332)
1. The effects of irreversible electroporation triggering anti-tumor immunity and the value of its combination with immunotherapy.
Li H; Zhou Y; Guo X; Zhang Q; Ding X
J Interv Med; 2023 Aug; 6(3):107-110. PubMed ID: 37846332
[TBL] [Abstract][Full Text] [Related]
2. Irreversible Electroporation for Locally Advanced Pancreatic Cancer.
Timmer FEF; Geboers B; Ruarus AH; Schouten EAC; Nieuwenhuizen S; Puijk RS; de Vries JJJ; Meijerink MR; Scheffer HJ
Tech Vasc Interv Radiol; 2020 Jun; 23(2):100675. PubMed ID: 32591191
[TBL] [Abstract][Full Text] [Related]
3. Irreversible Electroporation in Pancreatic Cancer-An Evolving Experimental and Clinical Method.
Gajewska-Naryniecka A; Szwedowicz U; Łapińska Z; Rudno-Rudzińska J; Kielan W; Kulbacka J
Int J Mol Sci; 2023 Feb; 24(5):. PubMed ID: 36901812
[TBL] [Abstract][Full Text] [Related]
4. Irreversible Electroporation: A Novel Ultrasound-guided Modality for Non-thermal Tumor Ablation.
Hsiao CY; Huang KW
J Med Ultrasound; 2017; 25(4):195-200. PubMed ID: 30065492
[TBL] [Abstract][Full Text] [Related]
5. Irreversible Electroporation: An Emerging Immunomodulatory Therapy on Solid Tumors.
Zhang N; Li Z; Han X; Zhu Z; Li Z; Zhao Y; Liu Z; Lv Y
Front Immunol; 2021; 12():811726. PubMed ID: 35069599
[TBL] [Abstract][Full Text] [Related]
6. [Research Progress of Catheter-based Irreversible Electroporation for Tissue Ablation].
Zhou Y; Han X; Ren F; Li Q; Chen X; Chu D; Wu R; Lyu Y
Zhongguo Yi Liao Qi Xie Za Zhi; 2020 Feb; 44(2):172-178. PubMed ID: 32400994
[TBL] [Abstract][Full Text] [Related]
7. Irreversible electroporation in primary and metastatic hepatic malignancies: A review.
Lyu T; Wang X; Su Z; Shangguan J; Sun C; Figini M; Wang J; Yaghmai V; Larson AC; Zhang Z
Medicine (Baltimore); 2017 Apr; 96(17):e6386. PubMed ID: 28445252
[TBL] [Abstract][Full Text] [Related]
8. [Irreversible electroporation: local tumor ablation with systemic immune effect].
Geboers B; Timmer FEF; van den Tol PM; de Gruijl TD; Scheffer HJ; Meijerink MR
Ned Tijdschr Geneeskd; 2021 Sep; 165():. PubMed ID: 34854585
[TBL] [Abstract][Full Text] [Related]
9. Irreversible electroporation and electrochemotherapy in oncology: State of the art.
Tasu JP; Tougeron D; Rols MP
Diagn Interv Imaging; 2022 Nov; 103(11):499-509. PubMed ID: 36266192
[TBL] [Abstract][Full Text] [Related]
10. Irreversible electroporation for the ablation of liver tumors: are we there yet?
Charpentier KP
Arch Surg; 2012 Nov; 147(11):1053-61. PubMed ID: 23165618
[TBL] [Abstract][Full Text] [Related]
11. Technology of irreversible electroporation and review of its clinical data on liver cancers.
Cohen EI; Field D; Lynskey GE; Kim AY
Expert Rev Med Devices; 2018 Feb; 15(2):99-106. PubMed ID: 29307242
[TBL] [Abstract][Full Text] [Related]
12. Midterm Safety and Efficacy of Irreversible Electroporation of Malignant Liver Tumors Located Close to Major Portal or Hepatic Veins.
Distelmaier M; Barabasch A; Heil P; Kraemer NA; Isfort P; Keil S; Kuhl CK; Bruners P
Radiology; 2017 Dec; 285(3):1023-1031. PubMed ID: 28799842
[TBL] [Abstract][Full Text] [Related]
13. Exploration of Novel Pathways Underlying Irreversible Electroporation Induced Anti-Tumor Immunity in Pancreatic Cancer.
Imran KM; Nagai-Singer MA; Brock RM; Alinezhadbalalami N; Davalos RV; Allen IC
Front Oncol; 2022; 12():853779. PubMed ID: 35372046
[TBL] [Abstract][Full Text] [Related]
14. Irreversible Electroporation in Interventional Oncology: Where We Stand and Where We Go.
Savic LJ; Chapiro J; Hamm B; Gebauer B; Collettini F
Rofo; 2016 Aug; 188(8):735-45. PubMed ID: 27074423
[TBL] [Abstract][Full Text] [Related]
15. Irreversible Electroporation Enhanced by Radiofrequency Ablation: An In Vitro and Computational Study in a 3D Liver Tumor Model.
Fang Z; Mao H; Moser MAJ; Zhang W; Qian Z; Zhang B
Ann Biomed Eng; 2021 Sep; 49(9):2126-2138. PubMed ID: 33594637
[TBL] [Abstract][Full Text] [Related]
16. Comparison of combination therapies in the management of locally advanced pancreatic cancer: Induction chemotherapy followed by irreversible electroporation vs radiofrequency ablation.
He C; Wang J; Zhang Y; Cai Z; Lin X; Li S
Cancer Med; 2020 Jul; 9(13):4699-4710. PubMed ID: 32410380
[TBL] [Abstract][Full Text] [Related]
17. Irreversible Electroporation.
Narayanan G
Semin Intervent Radiol; 2015 Dec; 32(4):349-55. PubMed ID: 26622097
[TBL] [Abstract][Full Text] [Related]
18. Thermodynamic profiling during irreversible electroporation in porcine liver and pancreas: a case study series.
Agnass P; van Veldhuisen E; Vogel JA; Kok HP; de Keijzer MJ; Schooneveldt G; de Haan LR; Klaessens JH; Scheffer HJ; Meijerink MR; van Lienden KP; van Gulik TM; Heger M; Crezee J; Besselink MG
J Clin Transl Res; 2020 Apr; 5(3):109-132. PubMed ID: 32617426
[TBL] [Abstract][Full Text] [Related]
19. Treatment of pancreatic cancer with irreversible electroporation and intratumoral CD40 antibody stimulates systemic immune responses that inhibit liver metastasis in an orthotopic model.
Shankara Narayanan JS; Hayashi T; Erdem S; McArdle S; Tiriac H; Ray P; Pu M; Mikulski Z; Miller A; Messer K; Carson D; Schoenberger S; White RR
J Immunother Cancer; 2023 Jan; 11(1):. PubMed ID: 36634919
[TBL] [Abstract][Full Text] [Related]
20. Single-center nonrandomized clinical trial to assess the safety and efficacy of irreversible electroporation (IRE) ablation of liver tumors in humans: Short to mid-term results.
Frühling P; Nilsson A; Duraj F; Haglund U; Norén A
Eur J Surg Oncol; 2017 Apr; 43(4):751-757. PubMed ID: 28109674
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
